Shimiao Zhu, Changyi Quan. "Adjuvant toripalimab in high-risk renal cell carcinoma after tumor resection (TUOAD-RCC): A prospective phase 2 study.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.e16520